Ba. Chizh et al., A COMPARISON OF INTRAVENOUS NBQX AND GYKI-53655 AS AMPA ANTAGONISTS IN THE RAT SPINAL-CORD, British Journal of Pharmacology, 112(3), 1994, pp. 843-846
1 The effects of intravenous administration of two alpha-amino-3-hydro
xy-5-methylisoxazole-4-pr acid (AMPA) antagonists were studied on resp
onses of single neurones to iontophoretically applied excitatory amino
acids. The tests were performed on spinal neurones in alpha-chloralos
e anaesthetized, spinalized rats. 2 Both the quinoxaline, NBQX (2-16 m
g kg(-1)) and the 2,3-benzodiazepine, GYKI 53655 (2-8 mg kg(-1)) dose-
dependently decreased responses to AMPA. 3 Both compounds were short a
cting, with half-recovery times of 15 min for NBQX and 7 min for GYKI
53655. 4 The selectivity for responses to AMPA over those to. N-methyl
-D-aspartate (NMDA) was significantly poorer for systemic NBQX than fo
r either systemic GYKI 53655 or iontophoretic NBQX, suggesting that sy
stemic NBQX may be converted to a less selective metabolite. 5 GYKI 53
655 is therefore likely to be a more valuable tool than NBQX for the s
tudy of AMPA receptor-mediated processes in vivo.